Discover the latest breakthroughs in dermatology from the 2024 Fall Clinical Dermatology Conference. This article reviews new findings on tralokinumab for atopic dermatitis (AD) and delgocitinib cream for chronic hand eczema (CHE).
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.